US Supreme Court refuses Cubicin patent infringement case

01-06-2016

US Supreme Court refuses Cubicin patent infringement case

Gary Blakeley / Shutterstock.com

The US Supreme Court has refused to review Cubist Pharmaceuticals’ infringement case over the antibiotic drug Cubicin (daptomycin).


US Supreme Court, Cubicin, Cubist, Hospira, patent

LSIPR